Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Expanded Access (Compassionate Use) Program for AVM0703

Next Previous
X
Search
Trial Profile

An Expanded Access (Compassionate Use) Program for AVM0703

Status: Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 02 Aug 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dexamethasone (Primary) ; Hydrocortisone; Proton pump inhibitors
  • Indications Adenocarcinoma; Advanced breast cancer; CNS cancer; Colon cancer; Diffuse large B cell lymphoma; Gastric cancer; Glioblastoma; Hodgkin's disease; Non-small cell lung cancer; Oesophageal cancer; Ovarian cancer; Precursor cell lymphoblastic leukaemia-lymphoma; Prostate cancer; Soft tissue sarcoma; Squamous cell cancer
  • Focus Expanded access; Therapeutic Use
  • Sponsors AVM Biotechnology

    • Most Recent Events

    • 01 Aug 2023 According to an AVM Biotechnology media release, 28 solid tumor and blood cancer patients have been treated in this study.
    • 19 Apr 2022 According to an AVM Biotechnology media release, an update on the startling results in a patient enrolled in the program will be provided at the Life Science Innovation Northwest.
    • 19 Apr 2022 Status changed from planning to recruiting, according to an AVM Biotechnology media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top